Himalaya Nutravedics India Limited logo

Himalaya Nutravedics India IPO: GMP, subscription and allotment status

SMEKFin TechnologiesListed29 Sept

—No subscription figures

Listed at
₹118
+11.3% on issue price
Est. listing
—
No estimate
Price band
₹100–106
Lot
1,200 shares
Min. ₹1,27,200

Allotment

Allotment is published. Check every saved PAN in one go.

Check allotment

Dates

22 → 24 Sept · allot 25 · list 29

Refunds and shares in your demat account on 28 Sept.

Subscription by category

Subscription figures here come from NSE's bid data, and this issue bids on BSE SME, so there are none on this page.

See this IPO on IPOWatch

GMP day by day

The last GMP before listing was ₹0 on 28 Sept, pointing to a listing around ₹106. It listed at ₹118, ₹12 above that estimate.

29 Sept 2026
GMP ₹0
Est. listing ₹106 0.0%
28 Sept 2026
GMP ₹0
Est. listing ₹106 0.0%
27 Sept 2026
GMP ₹0
Est. listing ₹106 0.0%
26 Sept 2026
GMP ₹0
Est. listing ₹106 0.0%
25 Sept 2026
GMP ₹0
Est. listing ₹106 0.0%
24 Sept 2026
GMP ₹0
Est. listing ₹106 0.0%

Recorded once a day from IPOWatch's GMP table. GMP is unofficial and doesn't guarantee a listing price.

Issue details

Segment
SME
Face value
₹10
Issue type
Book-building Issue
Fresh issue
₹26.50 Crores
Listing at
BSE SME
Registrar
KFin Technologies
NSE symbol
—

GMP is unofficial and doesn't guarantee a listing price. Where these numbers come from

What you can apply for

Retail Minimum
2 lots, 2,400 shares
₹2,54,400
Retail Maximum
2 lots, 2,400 shares
₹2,54,400
S-HNI Minimum
3 lots, 3,600 shares
₹3,81,600
S-HNI Maximum
7 lots, 8,400 shares
₹8,90,400
B-HNI Minimum
8 lots, 9,600 shares
₹10,17,600

A retail application can't go past ₹2 lakh; bigger bids go in the HNI categories.

Where the money goes

Funding Working Capital Requirements
₹13.75 Cr
Business Development and Digital Marketing Activities
₹7.50 Cr
General Corporate Purposes
—

What the company plans to do with the money it raises, from the offer document. Money raised in an offer for sale goes to the selling shareholders, not the company.

Company numbers

Revenue, ₹ crore

₹43.12 Cr+105.3% on 2025

Profit, ₹ crore

₹7.39 Cr+231.4% on 2025

Assets, ₹ crore

₹24.42 Cr+125.7% on 2025

2026
Revenue ₹43.12
Profit ₹7.39
2025
Revenue ₹21.00
Profit ₹2.23
2024
Revenue ₹14.43
Profit ₹0.43

In ₹ crore, for the years the offer document reports.

ROE
63.87%
ROCE
36.41%
EBITDA Margin
18.82%
PAT Margin
17.16%
Debt to equity ratio
0.31
Earning Per Share (EPS)
₹12.05 (Basic)
Return on Net Worth (RoNW)
45.12%
Net Asset Value (NAV)
₹26.70

Listed peers

Jeena Sikho Lifecare Limited
P/E 106.03
EPS 7.30
Sandu Pharmaceuticals Limited
P/E 21.34
EPS 1.83

Price to earnings, earnings per share and return on net worth, as the offer document reports them.

Who the issue is reserved for

QIB
50%
NII
15%
Retail
35%

Share of the issue set aside for each kind of investor.

Promoters and bankers

Promoters
Rohit Asawa, Divya Asawa, Chanda Asawa and Rama Raju Penmatsas
Promoter holding
95.14% before the IPO, 68.13% after
Lead managers
Nirbhay Capital Services Pvt. Ltd.

Issue details come from the IPO's page on IPOWatch, which follows the company's prospectus.

More SME IPOs

Frequently asked questions

When does Himalaya Nutravedics India IPO open and close?
Bidding ran from 22 September 2026 to 24 September 2026.
What is the Himalaya Nutravedics India IPO allotment date?
Allotment is out. You can check it by PAN now.
When will Himalaya Nutravedics India IPO list?
It listed on 29 September 2026.
How did Himalaya Nutravedics India IPO list against its GMP?
The last grey-market premium before listing was ₹0 on 28 September 2026, pointing to a listing around ₹106. It listed at ₹118, ₹12 above that estimate.
What is the lot size and minimum investment for Himalaya Nutravedics India IPO?
One lot is 1,200 shares, so the minimum investment at the upper price of ₹106 is ₹1,27,200.
How do I check Himalaya Nutravedics India IPO allotment status?
KFin Technologies has published the allotment. Use Check allotment on this page to check every PAN in your family in one go.